Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | -29 | 64,070 | 240 | 1,214 | 3,032 |
| Cost of Goods | N/A | 26 | -11 | 11 | N/A |
| Gross Profit | -29 | 64,044 | 251 | 1,203 | 3,032 |
| Operating Expenses | 132,261 | 111,991 | 173,683 | 119,631 | 142,579 |
| Operating Income | -132,290 | -47,921 | -173,443 | -118,417 | -139,547 |
| Other Income | 6,765 | 4,861 | 10,470 | 7,629 | 18,598 |
| Pre-tax Income | -125,525 | -43,060 | -162,973 | -110,788 | -120,949 |
| Income Tax | 170 | -137 | 168 | 170 | 16 |
| Net Income Continuous | -125,695 | -42,923 | -163,141 | -110,958 | -120,965 |
| Net Income | $-125,695 | $-42,923 | $-163,141 | $-110,958 | $-120,965 |
| EPS Basic Total Ops | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 |
| EPS Basic Continuous Ops | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 |
| EPS Diluted Total Ops | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 |
| EPS Diluted Continuous Ops | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 |
| EPS Diluted Before Non-Recurring Items | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 |
| EBITDA(a) | $-129,085 | $-43,474 | $-169,130 | $-112,979 | $-132,591 |